Success is when the time to access an innovative treatment is reduced.
CT-SCOUT™ is a multi-device application aiming at facilitating the recruitment of patients in clinical studies...
It assists the investigational team in detecting the studies for which a patient is potentially eligible according to his/her current health conditions.
Transforms all physician into real time recruiters
Anywhere, anytime
On any device
Easy to use
1. An efficient algorithmic model
2. Real-time detection
3. Simplified
process
Crohn disease
Ulcerative colitis
Rheumatoid arthritis
Ankylosing spondylitis
Psoriatic arthritis
Psoriasis
Atopic dermatitis
Hidradenitis suppurativa
200 +
studies registered (industrial & academic)
1000 +
users registered
170 +
centers in various countries (Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Switzerland, UK…)
7000 +
Patients detected
They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor. CT-SCOUT™and ToTem4me facilitate the match between the patients and the studies.
50%
OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES
However, millions of patients visit clinical sites every day.
CT-SCOUT™ help investigators identify the ones that could benefit from a clinical study.
80%
OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY
Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.
0.02%
OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY
But 80% of patients would accept to participate t a clinical study.
CT-SCOUT™ contributes to increase the percentage of patients considered for clinical research.
2
WEEKS SET-UP TIME
No more than 2 weeks are required to get CT-SCOUT™
or ToTem4me deployed for a clinical study
Assist investigational teams in their clinical research activities.
Shorten clinical trials by boosting detection of patients potentially eligible to clinical trials.
Allow patients’ earlier access to innovative and life-saving treatment.
April 30, 2024
May 14, 2024 – 1:15 PM to 2:00 PM (CEST) Join us for a comprehensive exploration of eTMF, where seasoned experts will discuss its significance, advantages, implementation challenges, regulatory compliance, and future trends. Our esteemed panel will share practical strategies and innovations to streamline eTMF utilisation in clinical trials. Our webinar will focus on an […]
April 30, 2024
Med City News Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions. Intellectual property can be a thorny issue in health tech and medtech. The intersection of healthcare data and AI is setting up […]
April 30, 2024
Med City News The nursing profession today is faced with a rising demand for care for an aging Baby Boomer population while simultaneously experiencing shortages related to a lack of educators, workforce geographic distribution, and high turnover. The American Association of Colleges of Nursing (AACN) reports that nursing schools are struggling to expand capacity to […]